Foresight Health® Globoid Cell Leukodystrophy
Our Foresight Health® single test for Globoid Cell Leukodystrophy is ideal for breeders and owners who want the reassurance of genetic health testing.
The guideline turnaround time for single tests is approximately 10-12 working days after the swab arrives at the lab.
If you need more than two tests it is often more cost-effective to order the relevant Foresight Health® breed package.
Globoid Cell Leukodystrophy (GCL) or Krabbe disease is a lysosomal storage disease which affects an enzyme during metabolism. From around six months of age signs include muscle weakness, lack of coordination, and body tremors. Progression can lead to blindness, paralysis, and death.
An autosomal recessive condition caused by a mutation in the GALC gene.
This test is also included in the following Foresight Health® breed packages: